The latest on the Rangers sale that everyone wants to pretend is inevitable:
Talks between the MLB Rangers and the team’s creditors are at an
impasse, sources said, all but ending any chance of the sale of the
team closing by Opening Day . . . “They have been at an impasse for weeks if not longer,” one source
said. “Baseball has been deluding itself. No idea how long it can go.”
MLB declined to comment.
How much longer the situation can drag on is unclear, with one
source saying in a few weeks the team could be forced into bankruptcy
In light of this, I’m wondering if MLB and Greenberg’s people are going to continue with the PR tack they’ve taken about all of this so far.
The Angels signed Japanese superstar Shohei Ohtani for a $2.3 million signing bonus last weekend. They may have damaged goods on their hands. Jeff Passan of Yahoo Sports reports that Ohtani underwent a physical that revealed a first-degree sprain of his ulnar collateral ligament. As a result, he got a platelet-rich plasma injection on October 20. This was made known to teams after Ohtani entered MLB’s posting system, so it wasn’t like the Angels went into this blind.
Ohtani’s report said, “Although partial damage of UCL in deep layer of his right UCL exists, he is able to continue full baseball participation with sufficient elbow care program.” It also said Ohtani “will most likely be available to start his throwing program approximately a month from the PRP.”
Passan notes that the report also mentioned that a “small free body” floats in Ohtani’s elbow near his UCL.
Ohtani isn’t without other injuries. He battled hamstring and ankle issues throughout 2017 and underwent right ankle surgery back in October. Thankfully for the Angels, this diagnosis is about as good as it could be considering the circumstances. However, if Ohtani does exacerbate his UCL issue, he may ultimately need Tommy John surgery at some point, which would take him out of action for at least a year.